• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性恢复的脑缺血患者是否更不稳定?

Are patients with acutely recovered cerebral ischemia more unstable?

作者信息

Johnston S Claiborne, Easton J Donald

机构信息

Department of Neurology, Box 0114, University of California at San Francisco, 505 Parnassus Ave, M-798, San Francisco, CA 94143-0114, USA.

出版信息

Stroke. 2003 Oct;34(10):2446-50. doi: 10.1161/01.STR.0000090842.81076.68. Epub 2003 Sep 4.

DOI:10.1161/01.STR.0000090842.81076.68
PMID:12958326
Abstract

BACKGROUND AND PURPOSE

Recent studies suggest that the short-term risk of stroke may be greater after transient ischemic attack (TIA) than after stroke.

METHODS

We compared risks of neurological deterioration in those with and without TIA in the National Institute of Neurological Disorders and Stroke (NINDS) tissue plasminogen activator (tPA) trial, a randomized trial of intravenous tPA given within 3 hours of onset of cerebral ischemia, after excluding those with cerebral hemorrhage and those dying before 90 days of causes other than new ischemic stroke. TIA was defined as a National Institutes of Health Stroke Scale (NIHSS) score of zero at 24 hours. We chose subsequent deterioration as our outcome, defined as a worsening on the NIHSS at 90 days compared with 24 hours, so that episodes of new ischemia that may have been attributed to other causes would be included.

RESULTS

Of 498 subjects meeting entry criteria, 40 (8%) had TIA. Subsequent deterioration occurred in 30% of those with TIA and 10% of others (P=0.001, Fisher exact test). In multivariable models with adjustment for age, sex, ethnicity, 24-hour NIHSS score, tPA administration, presumed stroke subtype, and baseline systolic blood pressure, temperature, and glucose, TIA was an independent predictor of subsequent deterioration (odds ratio, 5.0; 95% CI, 2.0 to 12.5; P=0.001). Subsequent deterioration was not associated with tPA treatment, and there was no interaction between tPA administration, TIA, and subsequent deterioration. Lesser degrees of substantial acute recovery were also associated with greater risk of subsequent deterioration.

CONCLUSIONS

Patients with TIA may be a greater risk of subsequent neurological deterioration from causes other than hemorrhage. Substantial acute recovery may be an indicator of greater instability more broadly.

摘要

背景与目的

近期研究表明,短暂性脑缺血发作(TIA)后发生卒中的短期风险可能高于卒中后。

方法

在国立神经疾病与卒中研究所(NINDS)组织型纤溶酶原激活剂(tPA)试验中,我们比较了有TIA和无TIA患者的神经功能恶化风险。该试验是一项随机试验,在脑缺血发作3小时内静脉给予tPA,排除了脑出血患者以及在90天内死于除新发缺血性卒中以外其他原因的患者。TIA定义为24小时时美国国立卫生研究院卒中量表(NIHSS)评分为零。我们选择随后的恶化作为结局指标,定义为90天时NIHSS评分较24小时时恶化,以便纳入可能归因于其他原因的新缺血发作。

结果

在498名符合入选标准的受试者中,40名(8%)有TIA。有TIA的患者中30%发生了随后的恶化,其他患者中为10%(P=0.001,Fisher精确检验)。在对年龄、性别、种族、24小时NIHSS评分、tPA给药、推测的卒中亚型以及基线收缩压、体温和血糖进行调整的多变量模型中,TIA是随后恶化的独立预测因素(比值比,5.0;95%CI,2.0至12.5;P=0.001)。随后的恶化与tPA治疗无关,tPA给药、TIA与随后的恶化之间也没有相互作用。急性恢复程度较低也与随后恶化的风险较高相关。

结论

TIA患者发生非出血性原因导致的随后神经功能恶化的风险可能更高。显著的急性恢复可能更广泛地表明更大的不稳定性。

相似文献

1
Are patients with acutely recovered cerebral ischemia more unstable?急性恢复的脑缺血患者是否更不稳定?
Stroke. 2003 Oct;34(10):2446-50. doi: 10.1161/01.STR.0000090842.81076.68. Epub 2003 Sep 4.
2
Early recovery after cerebral ischemia risk of subsequent neurological deterioration.
Ann Neurol. 2003 Oct;54(4):439-44. doi: 10.1002/ana.10678.
3
Poststroke neurological improvement within 7 days is associated with subsequent deterioration.卒中后7天内的神经功能改善与随后的病情恶化相关。
Stroke. 2004 Sep;35(9):2165-70. doi: 10.1161/01.STR.0000136554.03470.9d. Epub 2004 Jul 8.
4
The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.在SITS-MOST研究中,THRIVE评分可预测静脉注射组织型纤溶酶原激活剂(tPA)后症状性脑出血的发生。
Int J Stroke. 2014 Aug;9(6):705-10. doi: 10.1111/ijs.12335. Epub 2014 Jul 15.
5
The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial.THRIVE 评分预测了血管事件的总健康风险,独立于 NINDS tPA 试验中的溶栓治疗预测了缺血性卒中结局。
J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1111-6. doi: 10.1016/j.jstrokecerebrovasdis.2012.08.017. Epub 2012 Nov 2.
6
Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.急性缺血性卒中组织纤溶酶原激活剂诱导再通后早期动脉再闭塞的预测因素。
Stroke. 2005 Jul;36(7):1452-6. doi: 10.1161/01.STR.0000170711.43405.81. Epub 2005 Jun 9.
7
Clinical features and functional outcome of stroke after transient ischemic attack.短暂性脑缺血发作后卒中的临床特征和功能结局。
J Stroke Cerebrovasc Dis. 2013 Apr;22(3):260-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.08.010. Epub 2011 Oct 17.
8
Early risk and predictors of cerebrovascular and cardiovascular events in transient ischemic attack and minor ischemic stroke.短暂性脑缺血发作和小卒中的早期血管事件和心血管事件的风险和预测因素。
Neurol India. 2012 Mar-Apr;60(2):165-7. doi: 10.4103/0028-3886.96393.
9
Body temperature and major neurological improvement in tPA-treated stroke patients.溶栓治疗的脑卒中患者的体温与主要神经功能改善。
Acta Neurol Scand. 2014 May;129(5):325-9. doi: 10.1111/ane.12184. Epub 2013 Sep 20.
10
Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.日本 4 家医院组织中的组织型纤溶酶原激活物溶栓治疗急性缺血性脑卒中。
J Stroke Cerebrovasc Dis. 2013 Apr;22(3):190-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.016. Epub 2011 Oct 2.

引用本文的文献

1
Death and ADL Dependency After Scoring Zero on the NIHSS: A Swedish Retrospective Registry-Based Study.美国国立卫生研究院卒中量表评分为零后的死亡及日常生活活动能力依赖:一项基于瑞典回顾性登记的研究
Neurol Clin Pract. 2023 Oct;13(5):e200186. doi: 10.1212/CPJ.0000000000200186. Epub 2023 Sep 1.
2
Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.溶栓治疗的门到针时间与急性缺血性脑卒中患者 1 年死亡率和再入院率的关系。
JAMA. 2020 Jun 2;323(21):2170-2184. doi: 10.1001/jama.2020.5697.
3
The Role of Clopidogrel in 2020: A Reappraisal.
氯吡格雷在 2020 年的作用:再评价。
Cardiovasc Ther. 2020 Mar 16;2020:8703627. doi: 10.1155/2020/8703627. eCollection 2020.
4
Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388).强化抗血小板治疗与指南抗血小板治疗在近期缺血性卒中或短暂性脑缺血发作高危患者中的安全性和有效性:缺血性卒中后减少依赖三联抗血小板治疗(TARDIS)试验(ISRCTN47823388)的原理与设计
Int J Stroke. 2015 Oct;10(7):1159-65. doi: 10.1111/ijs.12538. Epub 2015 Jun 16.
5
Prediction factors of recurrent ischemic events in one year after minor stroke.轻度卒中后一年内复发性缺血性事件的预测因素。
PLoS One. 2015 Mar 16;10(3):e0120105. doi: 10.1371/journal.pone.0120105. eCollection 2015.
6
Thrombolysis for acute ischaemic stroke.急性缺血性卒中的溶栓治疗
Cochrane Database Syst Rev. 2014 Jul 29;2014(7):CD000213. doi: 10.1002/14651858.CD000213.pub3.
7
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design.新型短暂性脑缺血发作和小面积缺血性卒中(POINT)试验中的血小板导向抑制:原理与设计。
Int J Stroke. 2013 Aug;8(6):479-83. doi: 10.1111/ijs.12129.
8
Chromogranin a and the autonomic system: decomposition of heart rate variability and rescue by its catestatin fragment.嗜铬粒蛋白 A 与自主神经系统:心率变异性的分解及其 catestatin 片段的挽救
Endocrinology. 2010 Jun;151(6):2760-8. doi: 10.1210/en.2009-1110. Epub 2010 Apr 21.
9
Identifying diabetic patients with cardiac autonomic neuropathy by heart rate complexity analysis.通过心率复杂性分析识别患有心脏自主神经病变的糖尿病患者。
Biomed Eng Online. 2009 Jan 29;8:3. doi: 10.1186/1475-925X-8-3.
10
The use of neurovascular imaging for triaging TIA and minor stroke: implications for therapy.
Curr Treat Options Cardiovasc Med. 2006 May;8(3):235-41. doi: 10.1007/s11936-006-0017-7.